# Kos Partners Invests In Golden Age Health

> Kos Biotechnology Partners invests in Golden Age Health to expand rare disease access across Asia.
- Title: Kos Partners Invests In Golden Age Health · Pulse 2.0
- Summary: Kos Biotechnology Partners invests in Golden Age Health to expand rare disease access across Asia. Kos Biotechnology Partners invested in Golden Age Health…
- Keywords: kos biotechnology partners, golden age health, rare disease access, asia pacific, greater china, specialty pharmaceutical, startups, business, Kos, Partners, Invests, Golden
- Source: Pulse 2.0 — https://pulse2.com/kos-biotechnology-partners-invests-in-golden-age-health-to-expand-rare-disease-access-across-asia
- Author: Amit Chowdhry
- Published: 2026-10-27T19:24:20+00:00
- Read time: 1 min
- Topics: kos biotechnology partners, golden age health, rare disease access, asia pacific, greater china, specialty pharmaceutical, startups, business
## Strategic Investment
Kos Biotechnology Partners made a strategic investment in Golden Age Health through its inaugural Kos BioVentures fund.
## Alex Tzoukas Joins Board
Alex Tzoukas, Kos Biotechnology Partners Managing Partner and Co-Founder, joins Golden Age Health’s board of directors.
## Golden Age Health Mission
Golden Age Health is a Singapore-headquartered company focused on rare and specialty disease therapies for underserved populations in Greater China, Southeast Asia, and Gulf markets.
## Expansion Plans
The investment supports Golden Age Health’s expansion across Greater China and the Asia-Pacific region with cross-border biotech innovation movement.
## Key takeaway

Kos Biotechnology Partners invested in Golden Age Health to expand rare disease access across Greater China and the Asia-Pacific region.